Biotage completes the acquisition of PhyNexus, Inc. and resolves on a share issue as part of the acquisition

TUE, JAN 15, 2019 18:15 CET Stockholm – Biotage AB (publ) (Biotage) has today completed the acquisition of PhyNexus, Inc. (PhyNexus), which was announced on December 4, 2018. As part of the completion, the Board of Directors of Biotage has also, pursuant to an authorization granted by the Annual General Meeting 2018, resolved on a... Read more

Biotage acquires PhyNexus, Inc. and strengthens its position in lab-scale purification of biomolecules

TUE, DEC 04, 2018 07:45 CET Stockholm – Biotage AB (publ) (Biotage), (Nasdaq Stockholm: BIOT.ST) has today entered into an agreement to acquire all outstanding shares in the privately held company PhyNexus, Inc. (PhyNexus) based in California, US, for a total purchase price of approx. USD 21.5 million (corresponding to approx. SEK 195 million[1]) financed... Read more

PhyNexus, Inc. Enters Into An Agreement To Be Acquired By Biotage AB

SAN JOSE, Calif., Dec. 4, 2018 /PRNewswire/ — PhyNexus, Inc., a privately held California corporation, announces today an agreement to be acquired by Biotage AB (Nasdaq Stockholm: BIOT.ST), strengthening its position for world-wide sales and marketing of automated lab-scale purification technology of biomolecules. Together, PhyNexus and Biotage will be able to provide their global customers an enabling automation platform... Read more